These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32108042)

  • 1. Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics.
    Kwon OK; Ha YS; Na AY; Chun SY; Kwon TG; Lee JN; Lee S
    Cancer Genomics Proteomics; 2020; 17(2):195-208. PubMed ID: 32108042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed quantitative proteomics in prostate cancer biomarker development.
    Gao Y; Kim H; Kitata RB; Lin TT; Swensen AC; Shi T; Liu T
    Adv Cancer Res; 2024; 161():31-69. PubMed ID: 39032952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics in diagnosis of prostate cancer.
    Davalieva K; Polenakovic M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):5-36. PubMed ID: 26076772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer.
    Sequeiros T; Rigau M; Chiva C; Montes M; Garcia-Grau I; Garcia M; Diaz S; Celma A; Bijnsdorp I; Campos A; Di Mauro P; Borrós S; Reventós J; Doll A; Paciucci R; Pegtel M; de Torres I; Sabidó E; Morote J; Olivan M
    Oncotarget; 2017 Jan; 8(3):4960-4976. PubMed ID: 27903962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Proteome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteogenomics.
    Kwon OK; Ha YS; Lee JN; Kim S; Lee H; Chun SY; Kwon TG; Lee S
    Cancer Genomics Proteomics; 2019; 16(4):273-286. PubMed ID: 31243108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness.
    Liu Y; Chen J; Sethi A; Li QK; Chen L; Collins B; Gillet LC; Wollscheid B; Zhang H; Aebersold R
    Mol Cell Proteomics; 2014 Jul; 13(7):1753-68. PubMed ID: 24741114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of candidate biomarkers of prostate cancer progression in serum: a depletion-free 3D LC/MS quantitative proteomics pilot study.
    Larkin SE; Johnston HE; Jackson TR; Jamieson DG; Roumeliotis TI; Mockridge CI; Michael A; Manousopoulou A; Papachristou EK; Brown MD; Clarke NW; Pandha H; Aukim-Hastie CL; Cragg MS; Garbis SD; Townsend PA
    Br J Cancer; 2016 Oct; 115(9):1078-1086. PubMed ID: 27685442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of proteomics in prostate cancer research: biomarker discovery and validation.
    Pin E; Fredolini C; Petricoin EF
    Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel serological tumor markers for human prostate cancer using integrative transcriptome and proteome analysis.
    Han ZD; Zhang YQ; He HC; Dai QS; Qin GQ; Chen JH; Cai C; Fu X; Bi XC; Zhu JG; Liao DJ; Lu XP; Mo ZY; Zhu YP; Zhong WD
    Med Oncol; 2012 Dec; 29(4):2877-88. PubMed ID: 22215415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for prostate cancer.
    Schiffer E
    World J Urol; 2007 Dec; 25(6):557-62. PubMed ID: 17690889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics.
    Kwon OK; Jeon JM; Sung E; Na AY; Kim SJ; Lee S
    Cancer Genomics Proteomics; 2018; 15(4):279-290. PubMed ID: 29976633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic landscape profiling of primary prostate cancer reveals a 16-protein panel for prognosis prediction.
    Sun R; A J; Yu H; Wang Y; He M; Tan L; Cheng H; Zhang J; Wang Y; Sun X; Lyu M; Qu M; Huang L; Li Z; Zhang W; Ma K; Dong Z; Ge W; Zhang Y; Ding X; Yang B; Hou J; Xu C; Wang L; Zhu Y; Guo T; Gao X; Yang C
    Cell Rep Med; 2024 Aug; 5(8):101679. PubMed ID: 39168102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Identification of Small Extracellular Vesicle Proteins LAMB1 and Histone H4 for Prostate Cancer Diagnosis and Risk Stratification.
    Pang B; Wang Q; Chen H; Liu Z; Han M; Gong J; Yue L; Ding X; Wang S; Yan Z; Chen Y; Malouf D; Bucci J; Guo T; Zhou C; Jiang J; Li Y
    Adv Sci (Weinh); 2024 Jun; 11(23):e2402509. PubMed ID: 38590132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrative proteomics and interaction network-based classifier for prostate cancer diagnosis.
    Jiang FN; He HC; Zhang YQ; Yang DL; Huang JH; Zhu YX; Mo RJ; Chen G; Yang SB; Chen YR; Zhong WD; Zhou WL
    PLoS One; 2013; 8(5):e63941. PubMed ID: 23737958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RankProd Combined with Genetic Algorithm Optimized Artificial Neural Network Establishes a Diagnostic and Prognostic Prediction Model that Revealed C1QTNF3 as a Biomarker for Prostate Cancer.
    Hou Q; Bing ZT; Hu C; Li MY; Yang KH; Mo Z; Xie XW; Liao JL; Lu Y; Horie S; Lou MW
    EBioMedicine; 2018 Jun; 32():234-244. PubMed ID: 29861410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.
    Saraon P; Cretu D; Musrap N; Karagiannis GS; Batruch I; Drabovich AP; van der Kwast T; Mizokami A; Morrissey C; Jarvi K; Diamandis EP
    Mol Cell Proteomics; 2013 Jun; 12(6):1589-601. PubMed ID: 23443136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer.
    Barboro P; Repaci E; Rubagotti A; Salvi S; Boccardo S; Spina B; Truini M; Introini C; Puppo P; Ferrari N; Carmignani G; Boccardo F; Balbi C
    Br J Cancer; 2009 May; 100(10):1608-16. PubMed ID: 19401687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicle Proteome in Prostate Cancer: A Comparative Analysis of Mass Spectrometry Studies.
    Bernardino RMM; Leão R; Henrique R; Pinheiro LC; Kumar P; Suravajhala P; Beck HC; Carvalho AS; Matthiesen R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
    Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
    Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
    Li C; Zang T; Wrobel K; Huang JT; Nabi G
    Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.